New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- Tumbadchi Manjula (2026) Movie Review: A Delightful Marathi Comedy That Wins Hearts With Its Village Charm
- Mollywood Times (2026) Review: Naslen Shines in a Bold, Bittersweet Love-Hate Letter to Malayalam Cinema
- Sannidhanam P.O. Movie Review: A Devotional Drama That Speaks From the Heart
- The Pyramid Scheme Exposes the Fast-Money Dreams Destroying Middle-Class India
- Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
- Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
- Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
- Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging